- Email:
STEMOD™ Advanced Drug Discovery Service
Introduction
Advanced drug discovery integrates big data, AI, and 3D biology to support drug repurposing, target screening, and efficacy evaluation via high-precision models and computational analysis. It effectively reduces costs and improves success rates while overcoming the limitations of traditional models. We combine AI-driven screening, human-derived models, and repurposing strategies to deliver validated leads and reliable efficacy data, accelerating project progress and lowering clinical risks to turn early concepts into IND-ready candidates.
Discover How We Can Help - Request a Consultation →
Advanced CNS Drug Discovery
Our advanced CNS drug discovery platform supports target identification, lead optimization, efficacy evaluation, and safety assessment for neurodegenerative diseases, psychiatric disorders, and rare neurological conditions. It combines organoid models, electrophysiology, and high-throughput screening to simulate the in vivo neural microenvironment and predict clinical effects.
This platform integrates multi-dimensional functional detection and artificial intelligence analysis, with high stability and strong clinical translatability. It shortens research cycles, reduces clinical trial attrition rates, and provides reliable data support for IND filings and efficient development of innovative CNS drugs.
Fig.1 Scheme of the drug discovery process and the disciplines involved.1
Key Applications of Advanced CNS Drug Discovery
- Neurodegenerative disease drug development: For Alzheimer's, Parkinson's, ALS, and other progressive disorders, supporting target screening, efficacy testing, and mechanism studies.
- Psychiatric disorder research: Applied to schizophrenia, depression, and anxiety to evaluate drug effects on neural circuits and behavioral phenotypes.
- Rare neurological disease therapy: Modeling genetic neurologic diseases to enable precision drug discovery and gene therapy evaluation.
- Neurotoxicity & safety assessment: Early prediction of central and developmental neurotoxicity to reduce late-stage trial failure.
- Ion channel & receptor drug R&D: Screening neuromodulators, agonists, and antagonists for neurological indications.
- Gene & cell therapy evaluation: Assessing efficacy and safety of AAV, gene editing, and stem cell–based CNS therapies.
Workflow
The Advanced Drug Discovery workflow is a highly systematic process that transitions from digital intelligence to biological validation, ensuring every lead is stress-tested before major investment.
What We Can Offer
To support the rigorous demands of global biology experts, Creative Biolabs provides a specialized, industrial-scale platform for Basic Neuroscience Research Tool Preparation. We understand that high-quality tools—from viral vectors to neuroactive peptides—are the foundation of breakthrough discovery. Our customized service ensures your research tools meet the highest standards of stability, yield, and purity.
One-stop fermentation service
for neuro-reagents from laboratory scale and pilot scale to large-scale industrial volumes (4,000L to 12,000L).
Total capacity exceeding 100,000 liters
ensuring we can meet the demands of even the most extensive global drug discovery programs.
GMP-certified production
and strict aseptic verification procedures throughout the tool preparation process.
Optimized codon usage
and microorganism selection to maximize the expression of complex neural genes and peptides.
Guaranteed strain stability
in both master cell banks and large-scale fermentations, assessed by our qualified Quality Assurance (QA) service.
Quality-by-Design (QbD) and PAT
frameworks are integrated into upstream and downstream process development to ensure batch-to-batch consistency.
Flexible fermentation modes,
including batch, fed-batch, and continuous modes, are optimized specifically to maximize your product yield.
Full-scale QC & HACCP compliance
utilizing high-standard tools to quantify and evaluate product integrity for sensitive neuroscience applications.
Experience the Creative Biolabs Advantage - Get a Quote Today →
Customers Reviews
FAQs
Q: How does Creative Biolabs ensure the physiological relevance of its models?
A: We utilize STEMOD™ technology, which uses patient-derived iPSCs to create 3D organoids and organ-on-a-chip systems. These models mimic the human microenvironment far more accurately than traditional 2D cell lines or animal models.
Q: Can you assist with "rescuing" a drug candidate that failed in clinical trials?
A: Yes. Through our Precision Repurposing service, we use AI-driven indication mapping to identify new therapeutic uses for assets that may have lacked efficacy in their original indication but remain safe.
Q: What types of targets are compatible with your AI discovery platform?
A: Our platform is highly versatile, supporting GPCRs, kinases, ion channels, and even "undruggable" targets like multi-pass transmembrane proteins and protein-DNA interfaces.
Q: Is my data and intellectual property protected during the project?
A: Yes. Creative Biolabs operates under strict confidentiality agreements. All results, sequences, and optimized structures generated during the service remain the sole property of the client.
Q: How does your toxicity screening compare to standard assays?
A: We go beyond simple cell viability. Our MEA measurements and high-content imaging evaluate functional toxicity, such as electrophysiological changes in neurons or cardiomyocytes, providing a deeper safety profile.
Creative Biolabs provides an end-to-end platform for Advanced Drug Discovery, encompassing virtual screening, medicinal chemistry, iPSC-based disease modeling, and predictive toxicology. Our mission is to reduce R&D overhead and accelerate the delivery of life-changing therapies to patients.
Contact Our Team for More Information and to Discuss Your Project →
Reference
- Ciccone, Lidia, and Susanna Nencetti. "Special Issue "Advances in Drug Discovery and Synthesis"." International Journal of Molecular Sciences 26.2 (2025): 584. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ijms26020584.
For Research Use Only. Not For Clinical Use.